Geode Capital Management’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.71M Sell
1,546,240
-19,212
-1% -$34.9K ﹤0.01% 3008
2025
Q4
$3.68M Buy
1,565,452
+1,538,832
+5,781% +$2.96M ﹤0.01% 2925
2025
Q3
$22.9K Buy
26,620
+1,888
+8% +$1.48K ﹤0.01% 4404
2025
Q2
$16.8K Hold
24,732
﹤0.01% 4384
2025
Q1
$16.8K Buy
24,732
+14,680
+146% +$17.4K ﹤0.01% 4384
2024
Q4
$16.6K Buy
+10,052
New +$26.5K ﹤0.01% 4401
2024
Q2
Sell
-2,297
Closed -$13.7K 4611
2024
Q1
$13.7K Hold
2,297
﹤0.01% 4526
2023
Q4
$20.3K Hold
2,297
﹤0.01% 4512
2023
Q3
$20K Sell
2,297
-519
-18% -$9.52K ﹤0.01% 4624
2023
Q2
$71.8K Buy
+2,816
New +$70.3K ﹤0.01% 4432
2022
Q4
Sell
-173
Closed -$12K 4922
2022
Q3
$12K Hold
173
﹤0.01% 4968
2022
Q2
$53K Buy
173
+4
+2% +$1.93K ﹤0.01% 4762
2022
Q1
$134K Sell
169
-109
-39% -$88.1K ﹤0.01% 4548
2021
Q4
$271K Buy
278
+49
+21% +$85.6K ﹤0.01% 4343
2021
Q3
$454K Buy
229
+196
+594% +$433K ﹤0.01% 4075
2021
Q2
$100K Buy
33
+6
+22% +$27.2K ﹤0.01% 4562
2021
Q1
$202K Buy
+27
New +$182K ﹤0.01% 4112
2019
Q3
Sell
-1
Closed -$27K 4226
2019
Q2
$27K Hold
1
﹤0.01% 4142
2019
Q1
$37K Hold
1
﹤0.01% 4054
2018
Q4
$26K Hold
1
﹤0.01% 4065
2018
Q3
$88K Hold
1
﹤0.01% 3956
2018
Q2
$92K Hold
1
﹤0.01% 3882
2018
Q1
$137K Hold
1
﹤0.01% 3778
2017
Q4
$142K Hold
1
﹤0.01% 3743
2017
Q3
$109K Hold
1
﹤0.01% 3813
2017
Q2
$481K Hold
1
﹤0.01% 3367
2017
Q1
$417K Hold
1
﹤0.01% 3372
2016
Q4
$283K Hold
1
﹤0.01% 3479
2016
Q3
$328K Buy
+1
New +$314K ﹤0.01% 3427
2016
Q2
Hold
0
3694
2016
Q1
Hold
0
3381
2015
Q4
Hold
0
3273
2015
Q3
Hold
0
3171
2015
Q2
Hold
0
2965
2015
Q1
Hold
0
2893
2014
Q4
Hold
0
2648
2014
Q3
Hold
0
2470
2014
Q2
Hold
0
2424
2014
Q1
Hold
0
2467
2013
Q4
Hold
0
2879
2013
Q3
Hold
0
2853
2013
Q2
Hold
0
3054

Other funds holding PALI

Geode Capital Management's PALI Position: Q1 2026 in Review

Geode Capital Management reduced its Palisade Bio (PALI) stake by 1.2% in Q1 2026, selling an estimated $34.9K and leaving 1,546,240 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #3008.

Geode Capital Management first reported a position in PALI in Q3 2016 and has held it in 29 quarters since. The position peaked at $3.68M in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Geode Capital Management held 1,546,240 shares of Palisade Bio worth $2.71M as of Q1 2026.
  • Geode Capital Management sold 19,212 Palisade Bio shares in Q1 2026, an estimated $34.9K.
  • Palisade Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3008 holding.
  • Geode Capital Management first reported a position in Palisade Bio in Q3 2016 and has held it in 29 quarters since.
  • Geode Capital Management's Palisade Bio position peaked at $3.68M in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.